Sexual Health & Medical Wellness New Analysis Reveals Sertraline’s Early Impact on Core Depression and Anxiety Symptoms, Reshaping Treatment Timelines May 1, 2026 Susilo Ahmad A groundbreaking re-analysis led by researchers at University College London (UCL) has unveiled that sertraline, a widely prescribed antidepressant marketed as Zoloft and Lustral, initiates modest yet significant improvements in…
Sexual Health & Medical Wellness Sertraline Shows Early Modest Improvement in Key Depression and Anxiety Symptoms Within Two Weeks, UCL-Led Analysis Reveals. April 23, 2026 Susilo Ahmad A pioneering re-analysis spearheaded by researchers at University College London (UCL) has cast new light on the early efficacy of sertraline, a widely prescribed antidepressant sold under brand names such…
Sexual Health & Medical Wellness Sertraline Shows Early Symptom-Level Improvements in Depression and Anxiety Within Two Weeks, New UCL Analysis Reveals April 5, 2026 Susilo Ahmad A new, in-depth analysis led by researchers at University College London (UCL) has unveiled that sertraline, a widely prescribed antidepressant sold under brand names such as Zoloft and Lustral, can…
Sexual Health & Medical Wellness New Analysis Reveals Sertraline’s Earlier Impact on Emotional Symptoms of Depression and Anxiety March 29, 2026 Susilo Ahmad A significant re-evaluation of a widely used antidepressant, sertraline (marketed as Zoloft and Lustral), suggests it delivers modest yet measurable improvements in crucial emotional symptoms of depression and anxiety within…
Sexual Health & Medical Wellness Sertraline Shows Early Symptom-Level Improvements in Depression and Anxiety, New UCL Analysis Reveals March 22, 2026 Susilo Ahmad A recent and comprehensive analysis, spearheaded by researchers at University College London (UCL), has shed new light on the early therapeutic effects of sertraline, a widely prescribed antidepressant sold under…
